This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Yasuhiro Yamada: Innovator in Pharmaceutical Production
Introduction
Yasuhiro Yamada is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative processes for drug production. His work exemplifies the intersection of chemistry and medicine, aiming to improve the efficiency and purity of pharmaceutical compounds.
Latest Patents
Yamada holds a patent for a process for producing cilostazol, a medication used to treat intermittent claudication. The patent describes a method that enhances yield and purity by reacting a carbostyril derivative with a tetrazole derivative in the presence of an inorganic basic compound. This environmentally friendly process utilizes water in a specific weight ratio to the carbostyril derivative, ensuring a high-quality product. Yamada's patent is a testament to his commitment to advancing pharmaceutical manufacturing techniques. He has 1 patent to his name.
Career Highlights
Yasuhiro Yamada is associated with Otsuka Pharmaceutical Company, Limited, where he has contributed to various projects aimed at improving drug production methods. His expertise in chemical processes has been instrumental in developing innovative solutions that benefit the pharmaceutical industry.
Collaborations
Yamada has worked alongside talented colleagues, including Akihiro Yamamoto and Norihiro Fukuyama. Their collaborative efforts have fostered an environment of innovation and creativity within their projects.
Conclusion
Yasuhiro Yamada's contributions to pharmaceutical production highlight his role as an inventor dedicated to improving drug manufacturing processes. His innovative approach and commitment to quality continue to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
